Drug · DIN 02531925
KERENDIA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 22, 2022; first marketed November 22, 2022.
- Drug Identification Number (DIN)
- 02531925
- Company (DIN owner)
- Bayer Inc.Elkhart, Indiana, United States
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Finerenone C03DA05
- Class
- Human
- Record last updated
- February 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FINERENONE | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 14, 2022: NOC 29218New Drug Submission (NDS)
Other DINs named KERENDIA
- DIN 02531917 · Marketed
- DIN 02564726 · Approved